568 related articles for article (PubMed ID: 19017444)
1. Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings.
Scano F; Vitoria M; Burman W; Harries AD; Gilks CF; Havlir D
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1370-5. PubMed ID: 19017444
[TBL] [Abstract][Full Text] [Related]
2. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
[TBL] [Abstract][Full Text] [Related]
3. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.
Prasad R
Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336
[TBL] [Abstract][Full Text] [Related]
4. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW;
J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372
[TBL] [Abstract][Full Text] [Related]
5. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.
Yew WW
Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001
[TBL] [Abstract][Full Text] [Related]
6. Extensively drug-resistant tuberculosis: new strains, new challenges.
Banerjee R; Schecter GF; Flood J; Porco TC
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
[TBL] [Abstract][Full Text] [Related]
7. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
9. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
Chang KC; Yew WW
Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
[TBL] [Abstract][Full Text] [Related]
10. Methodological issues in the design of clinical trials for the treatment of multidrug-resistant tuberculosis: challenges and opportunities.
Lienhardt C; Davies G
Int J Tuberc Lung Dis; 2010 May; 14(5):528-37. PubMed ID: 20392344
[TBL] [Abstract][Full Text] [Related]
11. Drug-resistant TB and HIV in resource-limited settings: what TB/HIV programmes can learn from each other.
Colebunders R; Worodria W; Jones-López E; Joloba M; Apers L; Ellner J
Trop Med Int Health; 2008 Sep; 13(9):1204-7. PubMed ID: 18664238
[TBL] [Abstract][Full Text] [Related]
12. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
[TBL] [Abstract][Full Text] [Related]
13. Multidrug- and extensively drug-resistant tuberculosis in Africa and South America: epidemiology, diagnosis and management in adults and children.
Schaaf HS; Moll AP; Dheda K
Clin Chest Med; 2009 Dec; 30(4):667-83, vii-viii. PubMed ID: 19925960
[TBL] [Abstract][Full Text] [Related]
14. Management of multi-drug resistant tuberculosis: practitioner's view point.
Prasad R
Indian J Tuberc; 2007 Jan; 54(1):3-11. PubMed ID: 17455417
[TBL] [Abstract][Full Text] [Related]
15. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
Palacios E; Franke M; Muñoz M; Hurtado R; Dallman R; Chalco K; Guerra D; Mestanza L; Llaro K; Bonilla C; Sebastian J; Bayona J; Lygizos M; Anger H; Shin S
Int J Tuberc Lung Dis; 2012; 16(3):348-54. PubMed ID: 22640448
[TBL] [Abstract][Full Text] [Related]
16. Extensively drug-resistant tuberculosis--United States, 1993-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(11):250-3. PubMed ID: 17380107
[TBL] [Abstract][Full Text] [Related]
17. Tb drug resistance: is it really a threat to Africa?
Nunn P; Zignol M; Jaramillo E; Wright A; Getahun H
Ethiop Med J; 2007 Oct; 45(4):399-404. PubMed ID: 18326352
[TBL] [Abstract][Full Text] [Related]
18. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.
Mitrzyk BM
Pharmacotherapy; 2008 Oct; 28(10):1243-54. PubMed ID: 18823220
[TBL] [Abstract][Full Text] [Related]
19. Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa.
Migliori GB; Dheda K; Centis R; Mwaba P; Bates M; O'Grady J; Hoelscher M; Zumla A
Trop Med Int Health; 2010 Sep; 15(9):1052-66. PubMed ID: 20545927
[TBL] [Abstract][Full Text] [Related]
20. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality.
Gandhi NR; Shah NS; Andrews JR; Vella V; Moll AP; Scott M; Weissman D; Marra C; Lalloo UG; Friedland GH;
Am J Respir Crit Care Med; 2010 Jan; 181(1):80-6. PubMed ID: 19833824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
